The emerging role of cell-based assays in drug discovery

Handbook of Assay Development in Drug Discovery

Volumn , Issue , 2006, Pages 221-226

  Garippa, Ralph J ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42949097181     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (27)

1. Coates J, Causey A. Taking drug discovery into clinical development. Drug Information Association seminar, Melbourne, Australia, Dec 18, 1998.
2. Arch JRS. Lessons in obesity from transgenic animals. J Endocrinol Invest 2002; 25:867-875.
3. Figeys D. Adapting arrays and lab-on-a-chip technology for proteomics. Proteomics 2002; 2:373-382.
4. Heller MJ. DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng 2002; 4:129-153.
5. Semizarov D, Kroeger P, Fesik S. siRNA-mediated gene silencing: a global genome view. Nucl Acids Res 2004; 32:3836-3845.
6. Johnston PA, Johnston PA. Cellular platforms for HTS: three case studies. Drug Disc Today 7:353-363.
7. Schroeder K, Neagle BD. FLIPR: a new instrument for accurate high-throughput optical screening. J Biol Screening 1996; 1:75-80.
8. Cooke E-L, Ainscow E, Hargreaves A, Sullivan E, Alcock P, Ellston J, Peters S, Major J, Wannop J, Allen H, Plant D, Coudhry S, Hicks R, McCall E, Shaw J, Ronco L, Loomis C. G-protein-coupled receptor high throughput screen using Norak Transfluor technology and the In Cell Analyzer 3000. 9th Annual Society for Biomolecular Screening Conference, Portland, OR, Sept 21-25, 2003.
9. Garippa RJ. Use of the Evotec Opera confocal microscope imaging system to develop and complete an orphan GPCR high-throughput screening campaign using Norak Transfluor technology. 2nd Annual Cambridge Healthtech Institute High Content Analysis Conference, San Francisco, CA, Jan 25-28, 2005.
10. Guiliano K, Haskins J, Taylor DL. Advances in high content screening for drug discovery. Assay Drug Dev Technol 2003; 1:565-577.
11. Starkuviene V, Liebel U, Simpson JC, Erfle H, Poustka A, Weimann S, Pepperkok R. High-content screening microscopy identifies novel proteins with a putative role in secretory membrane trafficking. Genome Res 2004; 14:1948-1956.
12. Koppal T. Toxicogenomics warns of drug dangers. Drug Disc Devel 2004; 7:30-34.
13. Tencza S, Sipe MA. Detection and classification of threat agents via high-content assays of mammalian cells. J Appl Toxicol 2004; 24:371-377.
14. Boguslavsky J. Minimizing risks in hits to leads. Drug Disc Devel 2001; 4:26-30.
15. Schmid EF, Smith DA. Is pharmaceutical R&D just a game of chance or can strategy make a difference? Drug Disc Today 2004; 9:18-26.
16. Gonzalez JE, Oades K, Leychkis Y, Harootunian A, Negulescu, PA. Cell-based assays and instrumentation for screening ion-channel targets. Drug Disc Today 1999; 4:431-439.
17. Finlayson K, Witchel HJ, McCulloch J, Sharkey J. Acquired QT interval prolongation and hERG: implications for drug discovery and development. Eur J Pharmacol 2004; 500:129-142.
18. Brueggemann A, George M, Klau M, Beckler M, Steindl J, Behrends JC, Fertig N. Ion channel drug discovery and research: the automated nano-patch-clamp technology. Curr Drug Dis Technol 2004; 1:1570-1638.
19. Royer Y, Menu C, Liu X, Constantinescu S. High-throughput gateway bicistronic retroviral vectors for stable expression in mammalian cells: exploring the biological effects of STAT5 overexpression. DNA Cell Biol 2004; 23:355-365.
20. Clay WC, Condreay JP, Moore LB, Weaver SL, Watson MA, Kost TA, Lorenz JJ. Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cell. Assay Drug Dev Technol 2003; 1:801-810.
21. Sato Y, Shiraishi Y, Furuichi T. Cell specificity and efficiency of the Semliki forest virus vector-and adenovirus vector-mediated gene expression in mouse cerebellum. J Neurosci Meth 2004; 137:111-121.
22. Zhang Y, Kowal D, Kramer A, Dunlop J. Evaluation of FLIPR calcium 3 assay kit: a new no-wash fluorescence calcium indicator reagent. J Biomol Screen 2003; 8:571-577.
23. Gonzalez JE, Maher MP. Cellular fluorescent indicators and voltage/ion probe reader (VIPR™): tools for ion channel and receptor drug discovery. Recept Chan 2002; 8:283-295.
24. Wouters FS, Verveer PJ, Bastiaens PIH. Imaging biochemistry inside cells. Trends Cell Biol 2001: 11:203-211.
25. Schenborn E, Groskreutz D. Reporter gene vectors and assays. Mol Biotechnol 1999; 13:29-44.
26. Cowan C, Ouelette M, Payne R, Hudson C, Eckhardt A, Oakley R. Process improvements in cell delivery for GPCR high throughput screening. Tenth Annual Society for Biomolecular Screening Conference, Orlando, FL, USA, Sept 11-15, 2004.
27. McConnell HM, Owicki JC, Parce JW, Miller DL, Baxter GT, Wada HG, Pitchford S. The cytosensor microphysiometer: biological applications of silicon technology. Science 1992; 257:1906-1912.